Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/15/2009WO2009126639A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009WO2009126637A1 Antifolate compositions
10/15/2009WO2009126635A1 2-amino-benzothiazole derivates useful as inhibitors of rock kinases
10/15/2009WO2009126624A1 Triazolo compounds useful as dgat1 inhibitors
10/15/2009WO2009126606A2 Regression of established atherosclerotic plaques, and treating sudden-onset asthma attacks, using parp inhibitors
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126556A1 Pan-selectin inhibitor with enhanced pharmacokinetic activity
10/15/2009WO2009126551A2 Bis-aromatic anticancer agents
10/15/2009WO2009126537A1 Administration of an inhibitor of hdac and an hmt inhibitor
10/15/2009WO2009126535A1 Compounds and compositions as modulators of gpr119 activity
10/15/2009WO2009126530A2 Cgrp receptor antagonists
10/15/2009WO2009126527A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009126514A1 Compounds and compositions as kinase inhibitors
10/15/2009WO2009126513A1 Colchicine solid complex; methods of making; and methods of use thereof
10/15/2009WO2009126444A2 Compositions for the treatment of neurodegenerative conditions and methods for the use thereof
10/15/2009WO2009126401A1 Compositions of hydrophobic taxane derivatives and uses thereof
10/15/2009WO2009126335A2 Ant2 inhibitor compounds and methods of use thereof
10/15/2009WO2009126332A2 Method for treatment of amyotrophic lateral sclerosis using talampanel
10/15/2009WO2009126315A2 Macrocyclic compounds and methods of treatment
10/15/2009WO2009126305A1 Glucose metabolism modulating compounds
10/15/2009WO2009126274A2 Methods and compositions for the treatment of cancers, such as melanomas and gliomas
10/15/2009WO2009126175A1 Compositions of hydrophobic taxane derivatives and uses thereof
10/15/2009WO2009126174A1 Stable aqueous compositions comprising bioactive creatine species
10/15/2009WO2009126172A1 Resistance to polyphenon e due to increased bcl-2 expression
10/15/2009WO2009126145A1 Phosphate-binding chitosan and uses thereof
10/15/2009WO2009126123A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009125987A2 Pharmaceutical formulation
10/15/2009WO2009125981A2 Pharmaceutical formulation
10/15/2009WO2009125975A2 Combination of mitiglinide and metformin and process for preparing same
10/15/2009WO2009125944A2 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker
10/15/2009WO2009125873A1 Fused ring compounds and use thereof
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125858A1 Lipid dispersion preparation comprising 2-indolinone derivative
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125851A1 Method for detection of effectiveness of phenylalanine derivative-type compound in diabetes patient
10/15/2009WO2009125841A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
10/15/2009WO2009125819A1 Aminosugar compound and process for production thereof
10/15/2009WO2009125809A1 Piperidine derivatives
10/15/2009WO2009125808A1 Aminocyclohexyl derivative
10/15/2009WO2009125667A1 Water-based adhesive skin patch containing butenafine hydrochloride
10/15/2009WO2009125606A1 Pai-1 inhibitor
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009WO2009125434A2 Oxime derivatives
10/15/2009WO2009125433A2 Process for preparation of amine polymer salt
10/15/2009WO2009125415A1 Amorphous form of sildenafil citrate
10/15/2009WO2009125409A2 Fatty acid amides and uses thereof
10/15/2009WO2009125366A1 Substituted 2-phenyl-pyridine derivatives
10/15/2009WO2009125365A1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
10/15/2009WO2009125230A1 Pharmaceutical compounds
10/15/2009WO2009125226A1 Pharmaceutical depot comprising n-{5- t (cyclopropylamino) carbonyl] -2-methylphenyl}-3-flu0r0-4- (pyridin-2-ylmethox y) benzamide
10/15/2009WO2009125191A1 Benzene derivatives
10/15/2009WO2009125168A1 New combination for use in the treatment of inflammatory disorders
10/15/2009WO2009125140A2 Treatment of migraines without aura in pregnant women by inhalation of dioxygen gas
10/15/2009WO2009125117A2 Dermatological composition that can be used in particular for the care and prevention of eschars
10/15/2009WO2009125087A1 Divisible galenic form allowing modified release of the active ingredient
10/15/2009WO2009125042A1 Glycosylated indolecarbazoles, method for obtaining same and uses thereof
10/15/2009WO2009125029A1 Method for preparing amorphous combinations of angiotensin ii receptor antagonists and diuretics
10/15/2009WO2009125017A2 Process for the extraction of mangiferin and isomangiferin
10/15/2009WO2009124996A1 Anhydrous crystal form of orvepitant maleate
10/15/2009WO2009124984A1 Tablet comprising eprosartan mesylate
10/15/2009WO2009124983A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/15/2009WO2009124982A1 Granulation of active pharmaceutical ingredients
10/15/2009WO2009124973A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009WO2009124971A2 Novel compositions and their use
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124965A1 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009WO2009124956A1 Pyridine derivatives used to treat orexin related disorders
10/15/2009WO2009124950A2 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist
10/15/2009WO2009124940A1 Ivabradine hydrobromide
10/15/2009WO2009124909A1 Use of xanthone derivatives as a medicament for cancer
10/15/2009WO2009124883A1 Novel 1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124882A1 Novel piperidinyl-1,3-dihydro-benzoimidazol-2-ones as m1 agonists
10/15/2009WO2009124840A1 Compositions comprising myristic acid, fatty acids comprising a conjugated diene n‑5cis, n‑7trans or a conjugated triene n‑5cis, n‑7trans, n‑9cis
10/15/2009WO2009124756A1 Use of aprepitant and derivatives thereof for the treatment of cancer
10/15/2009WO2009124755A1 Compounds with novel medical uses and method of identifying such compounds
10/15/2009WO2009124746A1 Substituted sulfonamide derivatives
10/15/2009WO2009124734A2 Substituted sulfonamide derivatives
10/15/2009WO2009124733A1 Substituted sulfonamide derivatives
10/15/2009WO2009124702A1 Contraceptive estra-1,3,5(10)-triene derivatives
10/15/2009WO2009124693A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009124653A2 Thienopyrimidines
10/15/2009WO2009124638A1 Glucopyranoside derivatives
10/15/2009WO2009124636A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009WO2009124586A1 Aqueous pharmaceutical formulation
10/15/2009WO2009124552A2 Use of a combination of hypothermia inducing drugs
10/15/2009WO2009124551A2 Use of hypothermia inducing drugs
10/15/2009WO2009124468A1 Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof
10/15/2009WO2009124460A1 Tripterygium wilfordii diterpene lactone derivatives, their pharmaceutical compositions and their application in inhibiting tumour of reproductive system
10/15/2009WO2009124458A1 Phenylcyclobutylamide derivatives and their stereoisomers, the preparing processes and the uses thereof
10/15/2009WO2009124420A1 Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients
10/15/2009WO2009124399A1 Inhibition of cell migration by a farnesylated dibenzodiazepinone
10/15/2009WO2009124386A1 Combination therapy for the treatment of bacterial infections
10/15/2009WO2009124371A2 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
10/15/2009WO2009111695A8 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound
10/15/2009WO2009105278A3 Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells
10/15/2009WO2009105214A3 Selective androgen receptor modulators
1 ... 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 ... 7860